Livermore

Propel Bio Management, LLC

SEC CIK
0001969764

Holdings, Q2 2026

Positions as of Jun 30, 2026, filed Aug 13, 2026.SEC

Positions
29
−9 vs. Q1 2026
Total value
$191.09M
+$32.43M (+20.4%) vs. Q1 2026

Compare with Q1 2026: new, added, reduced and sold out

Positions

Long positions only. Changes compare share counts with Q1 2026.

Propel Bio Management, LLC holdings in Q2 2026
SecurityClassSharesValue% of portfolioChange in sharesActionHistory
PAGPPLAINS GP HLDGS L PLTD PARTNR INT A1,272,360$30.88M16.16%00.0%UnchangedView
ACHVACHIEVE LIFE SCIENCE INCCOM4,034,018$26.34M13.79%+247,593+6.5%AddedView
CORTCORCEPT THERAPEUTICS INCCOM136,499$11.87M6.21%−11,329−7.7%ReducedView
PHATPHATHOM PHARMACEUTICALS INCCOM1,050,358$11.4M5.96%+209,086+24.9%AddedView
DCTHDELCATH SYS INCCOM NEW871,460$10.97M5.74%−108,238−11.0%ReducedView
MISTMILESTONE PHARMACEUTICALS INCOM7,429,590$9.96M5.21%+3,311,269+80.4%AddedView
CMPSCOMPASS PATHWAYS PLCSPONSORED ADS573,086$8.11M4.24%−168,963−22.8%ReducedView
KYTXKYVERNA THERAPEUTICS INCCOM883,198$7.87M4.12%+238,777+37.1%AddedView
ARTVARTIVA BIOTHERAPEUTICS INCCOM696,436$6.76M3.54%+550,067+375.8%AddedView
ABEOABEONA THERAPEUTICS INCCOM NEW983,070$6.08M3.18%−346,829−26.1%ReducedView
AQSTAQUESTIVE THERAPEUTICS INCCOM1,442,397$6M3.14%+731,409+102.9%AddedView
PALIPALISADE BIO INCCOM2,582,388$5.4M2.82%+1,467,388+131.6%AddedView
IMUXIMMUNIC INCCOM NEW325,022$5M2.61%+325,022NewView
IVAINVENTIVA SAADS1,281,212$4.84M2.53%+556,534+76.8%AddedView
SABSSAB BIOTHERAPEUTICS INCCOM NEW1,076,578$4.2M2.20%+63,788+6.3%AddedView
OBIOORCHESTRA BIOMED HLDGS INCCOM896,701$3.87M2.02%00.0%UnchangedView
CLDXCELLDEX THERAPEUTICS INC NEWCOM NEW103,695$3.86M2.02%−27,669−21.1%ReducedView
ZVRAZEVRA THERAPEUTICS INCCOM NEW253,544$3.64M1.90%−28,874−10.2%ReducedView
OCULOCULAR THERAPEUTIX INCCOM357,966$3.52M1.84%−24,409−6.4%ReducedView
FDMT4D MOLECULAR THERAPEUTICS INCOM252,654$3.36M1.76%−127,766−33.6%ReducedView
OVIDOVID THERAPEUTICS INCCOM1,115,538$3M1.57%+194,081+21.1%AddedView
EYPTEYEPOINT INCCOM NEW191,745$2.74M1.43%−24,080−11.2%ReducedView
UPBUPSTREAM BIO INCCOM350,389$2.42M1.27%+8,610+2.5%AddedView
SCYXSCYNEXIS INCCOM543,478$2.21M1.16%+543,478NewView
SLNSILENCE THERAPEUTICS PLCADS191,733$2.11M1.10%+191,733NewView
LONALEONABIO INCCOM149,279$1.37M0.72%00.0%UnchangedView
MAZEMAZE THERAPEUTICS INCCOM43,798$1.31M0.68%00.0%UnchangedView
CRVSCORVUS PHARMACEUTICALS INCCOM70,380$1.05M0.55%−15,411−18.0%ReducedView
SGMTSAGIMET BIOSCIENCES INCCOM SER A125,878$973.04K0.51%+125,878NewView

Sold out since Q1 2026 (13)

Positions held at the end of Q1 2026 that are no longer in this filing.

Propel Bio Management, LLC positions sold out since Q1 2026
SecurityClassShares, Q1 2026Value, Q1 2026% of portfolio, Q1 2026
VORVOR BIOPHARMA INCCOM NEW314,543$5.59M3.52%
VRDNVIRIDIAN THERAPEUTICS INCCOM210,163$4.09M2.58%
OCSOCULIS HOLDING AGORDINARY SHARES122,223$3.28M2.07%
TRVITREVI THERAPEUTICS INCCOM223,802$2.65M1.67%
IMUXIMMUNIC INCCOM2,344,779$2.62M1.65%
CHRSCOHERUS ONCOLOGY INCCOM1,420,550$2.41M1.52%
KLRSKALARIS THERAPEUTICS INCCOM295,771$1.72M1.08%
QUREUNIQURE NVSHS104,772$1.71M1.08%
NUVBNUVATION BIO INCCOM CL A329,296$1.41M0.89%
EVMNEVOMMUNE INCCOM SHS55,664$1.28M0.81%
ALDXALDEYRA THERAPEUTICS INCCOM730,606$1.23M0.78%
CNTBCONNECT BIOPHARMA HLDGS LTDSHS209,493$553.91K0.35%
MSLESATELLOS BIOSCIENCE INCCOM10,145$57.12K0.04%

13F filings by quarter

Propel Bio Management, LLC 13F filings by quarter
QuarterFiledPositionsTotal valueChangesFiling
Q2 2026Aug 13, 202629$191.09Mvs. Q1 2026SEC
Q1 2026May 14, 202638$158.66Mvs. Q4 2025SEC
Q4 2025Feb 11, 202620$117.12Mvs. Q3 2025SEC
Q3 2025Nov 12, 202516$99.89Mvs. Q2 2025SEC
Q2 2025Aug 13, 202516$82.39Mvs. Q1 2025SEC
Q1 2025May 15, 202518$86.07Mvs. Q4 2024SEC
Q4 2024Feb 14, 202521$100.69Mvs. Q3 2024SEC
Q3 2024Nov 13, 202421$172.41Mvs. Q2 2024SEC
Q2 2024Aug 12, 202424$154.19Mvs. Q1 2024SEC
Q1 2024May 13, 202428$171.81Mvs. Q4 2023SEC
Q4 2023Feb 14, 202434$120.61M–SEC